Angiotensin receptor blocker and angiotensin-converting enzyme inhibitor use and survival in gastric cancer patients: a Finnish nationwide cohort study
Our study adds to the evidence that ARB use might have a beneficial impact on survival among GC patients.
Authors
- Panu Aaltonen (ORCID: https://orcid.org/0000-0002-2385-0601)
- Pauli Puolakkainen (ORCID: https://orcid.org/0000-0003-2489-4371)
- A. Auvinen
- Hanna Seppänen (ORCID: https://orcid.org/0000-0002-2529-651X)
- Caj Haglund (ORCID: https://orcid.org/0000-0003-0456-4965)
- Harri Mustonen (ORCID: https://orcid.org/0000-0001-5632-6796)
Institutions
- University of Helsinki (FI)
Publication Details
- Journal
- Gastric Cancer
- Published
- 2025-09-20
- DOI
- https://doi.org/10.1007/s10120-025-01662-2
- Primary Topic
- Renin-Angiotensin System Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Helsingin Yliopisto
- Mary och Georg C. Ehrnrooths Stiftelse